Immunogenicity and Safety of Homologous and Heterologous Prime-Boost of CoronaVac(®) and ChAdOx1 nCoV-19 among Hemodialysis Patients: An Observational Prospective Cohort Study

Background: Vaccines that prevent SARS-CoV-2 infection are considered the most promising approach to modulating the pandemic. There is scarce evidence on the efficacy and safety of different vaccine prime-boost combinations in MHD patients since most clinical trials have used homologous mRNA vaccine...

Descripción completa

Detalles Bibliográficos
Autores principales: Narongkiatikhun, Phoom, Noppakun, Kajohnsak, Chaiwarith, Romanee, Winichakoon, Poramed, Vongsanim, Surachet, Suteeka, Yuttitham, Pongsuwan, Karn, Kusirisin, Prit, Wongsarikan, Nuttanun, Fanhchaksai, Kanda, Khamwan, Chantana, Dankai, Dararat, Ophascharoensuk, Vuddhidej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146055/
https://www.ncbi.nlm.nih.gov/pubmed/37112627
http://dx.doi.org/10.3390/vaccines11040715

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146055/
https://www.ncbi.nlm.nih.gov/pubmed/37112627
http://dx.doi.org/10.3390/vaccines11040715

Ejemplares similares